Fidelity SPDR Advertisement
Home > Boards > Free Zone > Health and Sciences >

Biotech Values

RSS Feed
      Hide Sticky   Hide Intro
Moderator: DewDiligence Assistants: Biowatch
Search This Board:
Last Post: 9/20/2014 5:41:36 PM - Followers: 1106 - Board type: Free - Posts Today: 9
PostSubject
#182063  Sticky Note GILD pretty much confirmed Sofosbuvir/Ledipasvir FDC price will jq1234 09/20/14 12:49:05 AM
#182062  Sticky Note REGN > Regeneron says allergy drug may be biocqr 09/19/14 09:26:30 PM
#182058  Sticky Note TGTX Seeking Alpha Article/My Comment... bellweather1 09/19/14 12:10:01 PM
#182052  Sticky Note Annotations on ABBV/ENTA’s phase-2b dose-finding studies of ABT-493/ABT-530… DewDiligence 09/18/14 08:54:41 PM
#182039  Sticky Note Vivus and Auxilium (AUXL) announce FDA approval of Alyssa 09/18/14 08:51:50 AM
#181748  Sticky Note GILD—We now know that Stifel was indeed out DewDiligence 09/10/14 10:10:41 AM
#182071   Re: ABT-493 + ABT-530 (from #msg-106413637) It’s not DewDiligence 09/20/14 05:41:36 PM
#182070   <<I doubt I'll be interested [in GTCB]>> mouton29 09/20/14 01:03:05 PM
#182069   Noted in #msg-103874070. I doubt I'll be intersted, LOL. DewDiligence 09/20/14 12:12:05 PM
#182068   GTCB is baaaaaack! Well sort of. Angry Goat 09/20/14 12:05:54 PM
#182067   Nice call! Your $96K prediction for the US DewDiligence 09/20/14 10:54:08 AM
#182066   We will know in 4-6 weeks. Their shenanigan 09/20/14 10:45:00 AM
#182065   The company released this piece? Really? Sounds very ronpopeil 09/20/14 09:37:10 AM
#182064   Cellceutix to President Obama: We Have The Tools shenanigan 09/20/14 08:49:26 AM
#182063   GILD pretty much confirmed Sofosbuvir/Ledipasvir FDC price will jq1234 09/20/14 12:49:05 AM
#182062   REGN > Regeneron says allergy drug may be biocqr 09/19/14 09:26:30 PM
#182061   The military won't be fighting Ebola...the primary mission biocqr 09/19/14 08:49:07 PM
#182060   BABA's run-up today continuing to suck $Billions out GrthzGd 09/19/14 02:01:45 PM
#182059   NVO's Xultophy (IDegLira) was approved by EC yesterday: http://www.novonordisk jq1234 09/19/14 12:52:42 PM
#182058   TGTX Seeking Alpha Article/My Comment... bellweather1 09/19/14 12:10:01 PM
#182056   LPTN raises $12.5M in warrant-laden direct placement: DewDiligence 09/19/14 09:56:49 AM
#182055   NVO’s IDegLira* is going by the brand name, Xultophy: DewDiligence 09/19/14 09:40:00 AM
#182054   Ebola- From Virology Blog, the best thing I've oldberkeley 09/19/14 09:22:38 AM
#182053   Ebola - when evaluating the single arm (in iwfal 09/19/14 09:07:35 AM
#182052   Annotations on ABBV/ENTA’s phase-2b dose-finding studies of ABT-493/ABT-530… DewDiligence 09/18/14 08:54:41 PM
#182051   FDA approves LLY’s Trulicity (dulaglutide), a weekly GLP-1 DewDiligence 09/18/14 04:50:02 PM
#182050   In Europe look for competition from Vitaros[APRI]. Well north40000 09/18/14 12:51:16 PM
#182049   Credit Suisse - GED-0301 Domain Domination Coming Soon ariadndndough 09/18/14 12:18:39 PM
#182048   Foamix Pharmaceuticals (FOMX) IPOs 7.7M* shares @$6.00: DewDiligence 09/18/14 10:42:15 AM
#182047   ProQR Therapeutics (PRQR) IPOs 8.6M* shares @$13.00 and DewDiligence 09/18/14 10:35:54 AM
#182046   RPRX -24% on yesterday’s FDA panel regarding overtreatment DewDiligence 09/18/14 10:30:18 AM
#182045   NVO’s Ryzodeg hits primary endpoint in phase-3 trial: DewDiligence 09/18/14 10:19:18 AM
#182044   HALO—FDA removes clinical hold on phase-1/2 trial of DewDiligence 09/18/14 10:14:11 AM
#182043   The actual CVS data on Sovaldi usage are DewDiligence 09/18/14 10:03:55 AM
#182042   ENTA—Dworsky owns the shares as an individual and DewDiligence 09/18/14 10:00:24 AM
#182041   VVUS has a pretty consistent track record of ilpapa 09/18/14 09:46:59 AM
#182040   >>STENDRA is now the only FDA-approved erectile dysfunction biomaven0 09/18/14 09:33:55 AM
#182039   Vivus and Auxilium (AUXL) announce FDA approval of Alyssa 09/18/14 08:51:50 AM
#182038   Alan Dworsky reports 5.4% passive stake in Enanta Double_Bagel 09/18/14 08:17:30 AM
#182037   ENTA. Is this a new 5% holder? Double_Bagel 09/18/14 07:46:32 AM
#182036   Otc CTIX 2.42 Now the rally is strengthened shenanigan 09/18/14 05:13:59 AM
#182035   Over 8 percent of hepatitis C patients taking jbog 09/17/14 10:46:37 PM
#182034   Swedish Kancera making progress with ROR-inhibitor.Do you mcbio 09/17/14 10:13:46 PM
#182033   BMO MRK ariadndndough 09/17/14 07:39:40 PM
#182032   FLXN—FDA places clinical hold on FX006 phase-2b trial DewDiligence 09/17/14 06:13:13 PM
#182031   >>The CFO gave 6 months notice... hardly a biomaven0 09/17/14 05:57:37 PM
#182030   This is a problem for such companies as DewDiligence 09/17/14 05:55:21 PM
#182029   When Science Outpaces Payers: Molecular Diagnostics Pose Reimbursement biocqr 09/17/14 05:11:39 PM
#182028   Anybody has any opinions on today's CLVS ESMO Double_Bagel 09/17/14 04:21:57 PM
#182027   Doug, Thanks for all your reports on TGTX. Double_Bagel 09/17/14 04:19:37 PM
#182026   GSK Ebola vaccine ilpapa 09/17/14 03:38:44 PM
#182025   Swedish Kancera making progress with ROR-inhibitor. JohnStevenson 09/17/14 02:53:31 PM
#182024   $tgtx I sold today the few shares I masterlongevity 09/17/14 02:44:55 PM
#182023   Right, why isnt it surprising? BTH 09/17/14 01:57:06 PM
#182022   Today's TGTX Run/Thoughts/Prediction bellweather1 09/17/14 01:27:55 PM
#182021   TGTX up 15% imho investors digesting CS ariadndndough 09/17/14 12:27:23 PM
PostSubject